Monoamine Oxidase Inhibitors

Links shared publicly online about this topic

Toxicity, Monoamine Oxidase Inhibitor: eMedicine Emergency Medicine

emedicine.medscape.com — “Overview: Neurotransmitters are generally monoamines. They are manufactured, stored in vesicles in the nerve terminals, and then released through the plasma membrane into the synaptic cleft. When released into the synaptic space, neurotransmitters are either reabsorbed into ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 10:05 pm By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

MAOI poisoning can occur from overdose, drug-food interactions, or drug-drug interactions. Learn more. http://bit.ly/9CApFs

2 years ago...

Bipolar Disorder Medication Spotlight: Monoamine Oxidase Inhibitors (MAOI’s) | Bipolar Beat

zz.gd — “With this post, we continue our sort-of-biweekly series on medications used to treat bipolar disorder and related symptoms. Two weeks ago, we covered an olderView full resource at zz.gd

  • View Related
  • Share

Most Recently Shared on August 21, 2009 at 12:04 pm By:

psychcentral Psych Central Health Site

Bipolar Beat: Bipolar Disorder Medication Spotlight: Monoamine Oxidase Inhibitors (MAOI's) @http://zz.gd/2b409c

3 years ago...

Psychiatry Article | Monoamine Oxidase

mdlinx.com — “Monoamine oxidase inhibitor usage in HawaiiView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 27, 2010 at 6:51 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Monoamine oxidase inhibitor usage in Hawaii: Asian Journal of Psychiatry http://bit.ly/hGkI6l #PSY

1 year ago...

Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology

touchneurology.com — “Parkinson's disease, monoamine oxidase type B (MAO-B) inhibitors, rasagiline, selegiline, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, Rasagiline Mesylate (TVP-1012) in Early Monotherapy for PD Outpatients (TEMPO)View full resource at touchneurology.com

  • View Related
  • Share

Most Recently Shared on October 24, 2010 at 12:15 pm By:

Neurology Article | Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinsons Disease

mdlinx.com — “Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinsons DiseaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 29, 2011 at 8:04 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Tre... http://t.co/Sss1BxR7 #neuro

8 months ago...

Platelet Monoamine Oxidase Activity and Aggressive Obsessions | Psychiatry

touchpsychiatry.com — “Obsessive--compulsive disorder (OCD) is characterised by the repeated eruption in the mind of unwanted ideas, images or impulses described by the term --'obsessions--™.View full resource at touchpsychiatry.com

  • View Related
  • Share

Most Recently Shared on February 17, 2011 at 12:54 pm By:

TouchPsych Touch Psychiatry Medical Journal and Psychology

Platelet Monoamine Oxidase Activity and Aggressive Obsessions http://bit.ly/gstb3z

1 year ago...

Arch Gen Psychiatry -- Abstract: Monoamine Oxidase A Binding in the Prefrontal and Anterior Cingulate Cortices During Acute Withdrawal From Heavy Cigarette Smoking, August 2011, Bacher et al. 68 (8): 817

archpsyc.ama-assn.org — “Archives of General Psychiatry, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed articles about psychiatry and related fieldsView full resource at archpsyc.ama-assn.org

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 10:05 pm By:

ArchGenPsych ArchGenPsychiatry Medical Journal

Withdrawal from heavy cigarette smoking associated with brain imaging changes in regions related to mood regulation http://t.co/GIuLZ8M

10 months ago...

Access : Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation : Immunology and Cell Biology

nature.com — “Immunology and Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology. Areas that are covered include but are not limited to: Cellular immunology, Innate and adaptive immunity, Immune responses to pathogens,Tumour immunology,Immunopathology, Immunotherapy, Immunogenetics, Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)View full resource at nature.com

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 1:59 am By:

JuanCIvancevich Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician

Apocynin may be useful in the treatment of inflammatory diseases induced by oxidative stress through NOX activity http://bit.ly/kIQ3oB

11 months ago...

Study confirms Azilect as a selective MAO-B inhibitor

news-medical.net — “Teva Neuroscience Inc. today announced the publication of a study demonstrating the selectivity of Azilect® (rasagiline tablets) for inhibition of MAO-B (monoamine oxidase-B) at the maximum approved dose of 1 mg/day. The data was published in the Journal of Clinical Pharmacology OnlineFirst on May 5, 2010.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 4, 2010 at 11:52 am By:

Medicare_News News-Medical.Net Health News

Medicare News: Study confirms Azilect as a selective MAO-B inhibitor: Teva Neuroscience Inc. today announced the p... http://bit.ly/9HHPMA

2 years ago...

Depression: New Medications On The Horizon | Psych Central

psychcentral.com — “With the advent of monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) in the 1950s, depression treatment was revolutionized. TheseView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on January 18, 2011 at 5:55 pm By:

psychcentral Psych Central Health Site

New Article: Depression: New Medications On The Horizon http://bit.ly/gepMYR

1 year ago...

DailyMed: About DailyMed

dailymed.nlm.nih.gov — “DailyMed: About DailyMedView full resource at dailymed.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on October 10, 2010 at 3:35 am By:

Drugs_Devices Drugs and Devices OW OW Health

SCOT-TUSSIN DIABETES COUGH FORMULA WITH DM (Dextromethorphan Hydrobromide) Liquid [SCOT-TUSSIN Pharmacal Co., Inc.... http://bit.ly/bIHoH5

2 years ago...

FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions

drugs.com — “Azilect (rasagiline) is used for Parkinson’s Disease. Information from Drugs.com includes Azilect side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on December 15, 2009 at 10:13 pm By:

drugscom Drugs.com Health Site

FDA Approves New Prescribing Information for Azilect Reducing Medication and Food Restrictions - http://bit.ly/8BJT52

2 years ago...

FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions

medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) rView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 15, 2009 at 8:11 pm By:

mnt_parkinsons MNT Parkinson's News Health News

FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://mnt.to/3vwn

2 years ago...

CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression

medicalnewstoday.com — “CeNeRx BioPharma, Inc., reported that it has initiated a Phase II trial of its new formulation of TriRima™, the company's novel antidepressant in development as monotherapy for treatment resView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 7, 2011 at 3:05 pm By:

mnt_depression MNT Depression News Health News

CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression http://mnt.to/3PJS #depression

1 year ago...

Psychiatry Medical News about Depressive Disorder

mdlinx.com — “Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and RecurrenceView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 8, 2010 at 9:50 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Psychiatry: Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptak http://url4.eu/14juU

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • SusanS_Health

    Susan Scroggins

    Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.

    View Profile

  • psychcentral

    Psych Central

    Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390